✓ Last verified: February 22, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
At Axon Health Associates (previously known as Indy AT), those suffering from serious mental health issues and chronic pain receive first-class care. These conditions often relate to treatment-resistant depression, anxiety, and post-traumatic stress disorder, among others. The clinic’s board-certified psychiatrist, Dr. Jerad Dalton, manages intake and evaluation to ensure proper diagnosis for all prospective patients.
Known For: Axon Health Associates (formerly Indy Advanced Therapeutics) specializes in treatment-resistant mood disorders, offering Spravato (esketamine nasal spray), TMS therapy, and psychotherapy. Their multi-modal approach combines FDA-approved treatments with therapeutic support for patients who haven’t responded to traditional antidepressants.
| Google Reviews | ⭐ 3.7 (13 reviews) |
| Location | Indianapolis, Indiana |
| Address | 9245 N Meridian Street, Suite 225, Indianapolis, IN 46260 |
| Phone | (317) 899-9362 |
| Website | axonhealth.org |
| Treatments | Spravato (Esketamine Nasal Spray), TMS, Psychotherapy |
| Conditions Treated | Treatment-Resistant Depression, Anxiety, Mood Disorders |
| Cost | Contact clinic for pricing |
| Insurance | Contact clinic for accepted plans |
| KAP Available | Psychotherapy services offered alongside |
| Clinical Lead | Contact clinic |
HealingMaps Take: Axon Health Associates provides Spravato and TMS as alternatives to traditional IV ketamine infusions—giving Indianapolis patients multiple evidence-based options for treatment-resistant depression. The clinic’s combination of pharmacological and therapeutic approaches reflects a comprehensive model. Staff dedication to patient care, particularly around medication affordability, is a recurring positive in patient feedback.
Market Position: Axon Health Associates is a Spravato-certified clinic in the Indianapolis metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. Axon Health Associates has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Marion County, IN, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
The majority of ketamine patients moving from acute to maintenance phase report monthly maintenance sessions as the typical long-term cadence — balancing clinical efficacy with affordability. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 3-question summary is matched to the protocols and conditions Axon Health Associates treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Axon Health Associates offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Axon Health Associates treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Axon Health Associates treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
View all REMS-certified Spravato clinics in Indiana and across the United States.
Leave a Reply